Impact of Maternal COVID-19 Disease on Breast Milk and Infant Health (MilkCorona)
Impact of Maternal SARS-CoV-2 Infection and Vaccination on Breast Milk Antibodies, Milk Bioactive Compounds and Maternal-child Health (MilkCORONA)
Sponsor: Fetal Medicine Research Center, Spain
Listed as NCT04768244, this observational or N/A phase trial focuses on Covid19 and remains completed. Sponsored by Fetal Medicine Research Center, Spain, it has been updated 6 times since 2020, reflecting limited change activity. This study is part of the global effort to build evidence for infectious disease interventions.
Status Flow
Change History
6 versions recorded-
Oct 2025 — Present [monthly]
Completed
-
Sep 2024 — Oct 2025 [monthly]
Completed
-
Jul 2024 — Sep 2024 [monthly]
Completed
-
Nov 2023 — Jul 2024 [monthly]
Completed
Status: Recruiting → Completed
-
Apr 2022 — Nov 2023 [monthly]
Recruiting
▶ Show 1 earlier version
-
Mar 2021 — Apr 2022 [monthly]
Recruiting
First recorded
Apr 2020
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Fetal Medicine Research Center, Spain
- Hospital Clínico Universitario de Valencia
- Hospital Sant Joan de Deu
- Hospital Universitario Doctor Peset
- Hospital Universitario La Fe
- Institute of Agrochemistry and Food Technology, National Research Council
- Instituto de Investigacion Sanitaria INCLIVA
- Instituto de Investigación Sanitaria Aragón
- Universidad de Granada
- Universitat Jaume I
For direct contact, visit the study record on ClinicalTrials.gov .